Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Spatial transcriptomics has transformed our ability to study tissue architecture at molecular resolution, yet analyzing these data demands navigating dozens of computational methods across incompatible Python and R ecosystems---forcing researchers to devote more effort to making tools function than to pursuing biological questions. We present ChatSpatial, a platform in which the LLM selects from p...
Predicting how cells respond to chemical perturbations is one of the goals for building virtual cells, yet experimentally profiled compounds cover only a small fraction of this space. Existing models struggle to generalize to unprofiled compounds, as they typically treat drugs as isolated identifiers without encoding their mechanistic relationships. We present MAP, a framework that integrates stru...
Synthetic lethality (SL) offers a promising paradigm for targeted cancer therapy, yet experimental identification of SL gene pairs remains costly, con...
Medical oncology education faces a dual crisis: knowledge velocity that outpaces static curricula and large language model (LLM) risks hallucination a...
Clinical deployment of foundation models requires decision policies that operate under explicit error budgets, such as a cap on false-positive clinica...
Purpose: Castration-resistant prostate cancer (CRPC) is characterized by marked clinical heterogeneity and poor long-term survival, underscoring the n...
Differences in microbiome composition profoundly influence drug response, yet methods to model the metabolic interplay between tumors, microbes, and t...
Study Objectives Automated sleep staging underpins clinical sleep assessment and translational neuroscience, yet most data analyses work addresses hum...
Agent-based models of the tumor microenvironment (TME) traditionally rely on hand-coded rules that cannot generalize beyond their programmed logic. He...
The spatial organization of the tumor immune microenvironment (TIME) drives hepatocellular carcinoma (HCC) prognosis but remains unquantifiable on rou...
Cancer is often driven by specific combinations of an estimated two to nine gene mutations, known as multi-hit combinations. Identifying these combina...
Accurate brain tumor diagnosis requires models to not only detect lesions but also generate clinically interpretable reasoning grounded in imaging man...
Accurate prediction of malignancy in renal tumors is crucial for informing clinical decisions and optimizing treatment strategies. However, existing i...
Background: Although deep learning models have improved individual PET analysis, image processing and quantification tasks, end-to-end automation from...
Tumor drug response is profoundly shaped by cellular heterogeneity, making single-cell resolution essential for precision oncology. While drug-respons...
Therapeutic target discovery remains a critical yet intuition-driven bottleneck in drug development, typically relying on disease biologists to labori...
Deep intracranial tumors situated in eloquent brain regions controlling vital functions present critical diagnostic challenges. Clinical practice has ...
Extracting clinical information from medical transcripts in low-resource languages remains a significant challenge in healthcare natural language proc...
Applying deep learning models to RNA-Seq data poses substantial challenges, primarily due to the high dimensionality of the data and the limited sampl...
Deep learning has significantly advanced automated brain tumor diagnosis, yet clinical adoption remains limited by interpretability and computational ...